Dermocosmetic Treatment for ETR (Subtype 1)

[Guide]

A new dermocosmetic treatment done by some researchers at Induchem Companies, and Le CBM discovered some active ingredients to treat ETR, which is the most difficult rosacea subtype to treat.  

The dermocosmetic active ingredient is composed of three glucosylated derivatives of natural plants hydroxybenzoic acid and hydroxycinnamic acids (rosmarinic acid, gallic acid, and caffeic acid).  

The results of the study concluded, "the studies have shown that this active ingredient could be a dermocosmetic support, especially for erythematotelangiectatic rosacea armamentarium."

Clin Cosmet Investig Dermatol. 2015; 8: 501–510.
Published online 2015 Oct 1. doi:  10.2147/CCID.S92326
PMCID: PMC4598363
Combination of new multifunctional molecules for erythematotelangiectatic rosacea disorder
Hanane Chajra, [1] Mahdi Nadim, [2] Daniel Auriol,[3] Kuno Schweizer, [1] and Fabrice Lefèvre [1]
[1] Induchem AG, Volkestwil, Switzerland
[2] CBM-CNRS, Orléans Cedex, France
[3] Libragen SA, Toulouse, France